#67
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians treating older adults need current evidence about cannabis use patterns in this population since seniors are increasingly self-treating pain, insomnia, and mood disorders with cannabis despite limited safety data in geriatric patients. Understanding older adults’ motivations for cannabis use and the gaps in evidence-based information can help clinicians engage in informed discussions about efficacy, drug interactions with common medications, and fall risk in this vulnerable population. Development of evidence-based tools for discussing cannabis with older patients addresses a clinical care gap and may improve shared decision-making around pain and mental health management.
Older adults represent a rapidly growing demographic of cannabis users seeking relief from pain, anxiety, depression, and sleep disturbances, conditions that are highly prevalent in this population and often inadequately managed by conventional pharmacotherapy. This emerging trend reflects both patient-driven demand for alternative therapeutic options and a shifting landscape of cannabis legalization and availability, yet clinicians often lack adequate training and evidence-based frameworks to counsel older adults on cannabis use, efficacy, and safety considerations specific to aging physiology. The gap between patient interest and clinical guidance is particularly concerning given that older adults are at heightened risk for drug interactions, cognitive effects, and falls with cannabis use due to altered pharmacokinetics and polypharmacy. Research to develop evidence-based counseling tools and standardized information resources is critical to support shared decision-making and help older patients make informed choices aligned with their health goals and medical complexity. Clinicians should proactively initiate conversations about cannabis use with older adult patients, maintain current knowledge about cannabis pharmacology and safety in aging populations, and utilize emerging clinical decision-support tools to provide personalized, evidence-based guidance rather than defaulting to abstinence-only messaging or dismissing patient interest.
“We’re seeing a genuine shift in older adults turning to cannabis for pain, sleep, and mood, and I think that reflects both their frustration with conventional options and changing social attitudes, but we still lack the long-term safety and efficacy data in this population that we have for most medications, so my role is to help patients understand what we do and don’t know while supporting informed decision-making.”
🧓 Older adults represent a rapidly growing demographic of cannabis users, driven largely by self-perceived benefits for pain, anxiety, and insomnia—conditions highly prevalent in this population. While cannabis may offer symptom relief for some patients, clinicians should recognize that evidence in older adults remains limited, and age-related pharmacokinetic changes, polypharmacy concerns, and increased risk of cognitive and cardiovascular effects warrant careful consideration. The appeal of cannabis to this group may also reflect frustration with conventional treatments or limited access to multimodal pain management and mental health services rather than cannabis being objectively superior. When older patients inquire about cannabis, providers should conduct a thorough assessment of their specific symptoms, current medications, comorbidities, and fall risk rather than dismissing these interests outright. Establishing open, non-judgmental conversations about cannabis use and offering evidence-based alternatives—alongside targeted referrals to pain management, geriatric
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
